CareMax Inc

CareMax — Q1 2023 Earnings Presentation

14 slides from CareMax's earnings presentation, May 10, 2023

  1. Slide 1: First Quarter 2023 Earnings Presentation

    First Quarter 2023 Earnings Presentation May 10, 2023

  2. Slide 2: Disclaimer

    Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or

  3. Slide 3: CareMax is Driven by a Mission to Deliver Best-in-Class Care

    CareMax is Driven by a Mission to Deliver Best-in-Class Care ~96K Medicare Advantage Members1 62 CareMax Medical Centers1 5-Stars CMS Quality Rating2 ~268K Total Value-Based Care Members1 10 States1 As of March 31, 2023. Centers for Medicare & Medicaid Services 2022 Star rating across CareMax center

  4. Slide 4: First Quarter 2023 Update

    First Quarter 2023 Update Total Value-Based Care membership of 268,000, up 274% year-over year Medicare Advantage membership of 95,500, up 181% year-over-year Revenue of $173.0 million, up 26% year-over-year Net loss of $82.1 million, compared to net loss of $16.8 million for 1Q221 Adjusted EBITDA o

  5. Slide 5: Value-Based Care Membership Breakdown

    Value-Based Care Membership Breakdown ~268,000 Value-Based Care Lives ~95,500 Medicare Advantage1 Full-Risk 36% Other VBC2 62% ~33,500 Medicaid Other VBC2 97% ~33,500 Commercial Full-Risk 91% Other VBC2 9% ~107,000 MSSP & ACO REACH MSSP 92% ACO REACH 8% Note: As of March 31, 2023. 98% of MA patients

  6. Slide 6: Reaffirming Financial Outlook for Full Year 2023

    Reaffirming Financial Outlook for Full Year 2023 Note: Year over year growth may not compute due to rounding. Adjusted EBITDA is a non-GAAP number. For a reconciliation to the closest GAAP number, see supplement to this presentation. A reconciliation of projected 2023 Adjusted EBITDA to the most dir

  7. Slide 7: First Quarter 2023 Financial Supplement

    First Quarter 2023 Financial Supplement

  8. Slide 8: Reconciliation to Platform Contribution and Calculation of Medical Expense Ratio

    Reconciliation to Platform Contribution and Calculation of Medical Expense Ratio 1 2 Gross profit reflects the reclassification of stock compensation expense previously included in corporate, general and administrative expenses, which decreased gross profit by $0.4 million for the three months ended

  9. Slide 9: Reconciliation to Adjusted EBITDA

    Reconciliation to Adjusted EBITDA1 Net Income to Adjusted EBITDA Bridge 2 3 The Company has revised its presentation of Adjusted EBITDA to no longer add back de novo pre-opening costs and post-opening losses and has recast its prior presentation of Adjusted EBITDA. Represents initial costs to set up

  10. Slide 10: Non-GAAP Adjustments Detail

    Non-GAAP Adjustments Detail Represents consulting and legal costs directly associated with efforts related to integration of the two privately held companies that were combined in the Business Combination. Represents incremental compensation expense directly associated with efforts related to integr

  11. Slide 11: Non-GAAP Financial Summary

    Non-GAAP Financial Summary Adjusted EBITDA is calculated and presented after de novo pre-opening costs and post-opening losses. Non-GAAP Income Statement 1

  12. Slide 12: Illustrative Financial Impact of Prior Period Developments

    Illustrative Financial Impact of Prior Period Developments Excludes adjustments of approximately $0.3 million of other unfavorable prior period developments in revenue and $0.1 million of other favorable prior period developments in medical margin. Medicare and Medicaid risk medical margin equals Me

  13. Slide 13: Capitalization and Liquidity

    Capitalization and Liquidity Diluted Share Count Net Debt (Cash) Excludes unvested warrants as of March 31, 2023. Warrants have a strike price of $11.50/share and (other than the Related warrants) are subject to a $18.00 redemption cap. Warrants are currently out of the money based on CareMax’s clos

  14. Slide 14: Q&A

    Caremax Q&A

CareMax — Q1 2023 Earnings Presentation on 6ix